
Side Effects Make Viking’s Oral Obesity Drug a Tough Pill for Investors to Swallow
Viking Therapeutics’ obesity pill met weight reduction goals of its Phase 2 test, but gastrointestinal side effects led to high discontinuation rates. Even so, analysts see potential for a lower dose of the Viking drug as a maintenance therapy. The post Side Effects Make Viking’s Oral Obesity Drug a Tough Pill for Investors to Swallow…